Showing results (91-100 of 127) with videos related to
Sort By:
Pageof 13
Cancer Treatment Reviews|June 24, 2014
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitorsChristian Rolfo, Elisa Giovannetti, David S Hong, et al.British Journal of Cancer|November 1, 2018
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutationsFrancesco Passiglia, Federico Cappuzzo, Oscar Alabiso, et al.Frontiers in Oncology|September 25, 2020
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian <i>Onco-Covid</i> UnitMaria Lucia Reale, Paolo Bironzo, Valentina Bertaglia, et al.Critical Reviews in Oncology/Hematology|February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesotheliomaMarco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.Cells|October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung CancerAnnapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2020
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and RecommendationsJordi Remon, Francesco Passiglia, Myung-Ju Ahn, et al.Lung Cancer (Amsterdam, Netherlands)|November 15, 2022
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP)Antonio Passaro, Giuseppe Lo Russo, Francesco Passiglia, et al.Biomedicines|January 21, 2023
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center ExperienceIrene Persano, Massimiliano Cani, Benedetta Del Rio, et al.Lung Cancer (Amsterdam, Netherlands)|August 28, 2022
Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trialEnriqueta Felip, Egbert F Smit, Miguel A Molina-Vila, et al.European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patientsUmberto Malapelle, Francesco Passiglia, Chiara Cremolini, et al.Pageof 13